Home › NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone
 

Keywords :   


NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone

2015-11-18 20:49:12| Agriculture - Topix.net

Australian biopharmaceutical Company Immuron Limited is pleased to announce that the Company's Phase IIb, the IMM-124E clinical trial for the treatment of NASH , has successfully passed its 25% recruitment milestone with 35 patients having been successfully randomized into either arms. Immuron continues to drive its NASH clinical trial recruitment to meet its enrollment goal of 120 biopsy-proven NASH subjects by June 2016.

Tags: patient clinical trail recruitment

Category:Agriculture and Forestry

Latest from this category

All news
25.04U.S. beef, cattle demand posts early 2024 highs
25.04Goal setting reduces stress, increases confidence
25.04Selecting sires to create replacement females
25.04A step towards smart swine barns
25.04Alveo Technologies, NYtor to develop rapid test for swine influenza
25.04Baker recognized for renowned IAV research in swine
25.04Farm Progress America, April 25, 2024
25.04Farm Progress America, April 25, 2024
Agriculture and Forestry »
25.04Independent Beauty Association Celebrates 50 Years in the Industry
25.04Jack Mead Launches Vagaro Master Class for Salon & Beauty Professionals
25.04Hitachi Zosen Inova's (HZI's) Kompogas San Luis Obispo Facility Diverts 140,000 Tons of Waste
25.04WeedMe standardizes label production with Arrow Systems
25.04Veolia and Sewerage and Water Board of New Orleans Collaborate to Reinvent Wastewater Treatment
25.04Slicker Recycling and Safetykleen Partner on Carbon Cutting
25.04BlueTriton Brands Extends Environmental Plans
25.04Phoenix Energy sold to Hong Kong billionaire
More »